CA$
0. 29
+0.04
+18.3673%
CA$
15.28M Market Cap
- P/E Ratio
- Div Yield
56,000 Volume
- Eps
CA$ 0.24
Previous Close Want to track NTLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurothera Labs Inc. (NTLX) Statistics
Valuation metrics
Market Cap 15.28M
Enterprise value 20.75M
Trailing P/E (ttm) -2.95
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 17.85
Price/Book (mrq) -
Enterprise Value/Revenue 17.56
Enterprise Value/EBITDA -5.91
Overview
Shares outstanding 18.1M
Float 20.85M
Shares short 1
% Held by insiders 0.77%
% Held by institutions -
Average volume (10 days) 1K
Average volume (90 days) 633
Price summary
52-Week low 0.15
52-Week high 0.29
Beta -0.17
50-Day moving average 0.21
200-Day moving average 0.18
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Jul 2025
Profitability
Profit margin 0.74%
Operating margin -15.55%
Operational effectiveness
Return on assets -0.71%
Return on equity -3.99%
Income Statement
Revenue (ttm) 1.18M
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -0.23%
Gross profit (ttm) 871.13K
EBITDA -3.51M
Net income to common (ttm) -5.69M
Diluted EPS (ttm) -0.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 2.35M
Total cash per share (mrq) 0.02
Total debt (mrq) 1.29M
Total Debt/Equity (mrq) 144.14
Current ratio (mrq) 1.35%
Book value per share (mrq) -
Cash Flow
Cash flow statement -2.29M
Levered free cash flow (LFCF) -564.3K
